The association between glucose abnormalities and heart failure in the population-based Reykjavik study
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsThrainsdottir, Inga S
MetadataShow full item record
CitationDiabetes Care 2005, 28(3):612-6
AbstractOBJECTIVE: Diabetes is an independent risk factor for heart failure, whereas the relation between heart failure and abnormal glucose regulation (AGR) needs further evaluation. We studied this combination in the Reykjavik Study. RESEARCH DESIGN AND METHODS: The Reykjavik Study, a population-based cohort study during 1967-1997, recruited 19,381 participants aged 33-84 years who were followed until 2002. Oral glucose tolerance tests and chest X-rays were obtained from all participants. Cases were defined in accordance with World Health Organization criteria for type 2 diabetes or AGR (impaired glucose tolerance or impaired fasting glucose) and European Society of Cardiology guidelines for heart failure. RESULTS: The overall prevalence of type 2 diabetes and heart failure was 0.5% in men and 0.4% in women, while AGR and heart failure were found in 0.7% of men and 0.6% of women. Among participants with normal glucose regulation, heart failure was diagnosed in 3.2% compared with 6.0 and 11.8% among those with AGR and type 2 diabetes, respectively. The prevalence of type 2 diabetes in the age-group 45-65 years increased in both sexes during the period (P for trend = 0.007). The odds ratio was 2.8 (95% CI 2.2-3.6) for the association between type 2 diabetes and heart failure and 1.7 (1.4-2.1) between AGR and heart failure. CONCLUSIONS: There is a strong association between any form of glucometabolic perturbation and heart failure. Future studies in this field should focus on all types of glucose abnormalities rather than previously diagnosed diabetes only.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Link field
- Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavík Study.
- Authors: Thrainsdottir IS, Aspelund T, Hardarson T, Malmberg K, Sigurdsson G, Thorgeirsson G, Gudnason V, Rydén L
- Issue date: 2005 Oct
- [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
- Authors: Köhler C, Temelkova-Kurktschiev T, Schaper F, Fücker K, Hanefeld M
- Issue date: 1999 Sep 17
- Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.
- Authors: Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO
- Issue date: 2009 Jan 30
- High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes.
- Authors: Boonman-de Winter LJ, Rutten FH, Cramer MJ, Landman MJ, Liem AH, Rutten GE, Hoes AW
- Issue date: 2012 Aug
- [Prevalence of type II diabetes mellitus in population of Krakow].
- Authors: Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W
- Issue date: 2001 Sep